155 related articles for article (PubMed ID: 11684016)
21. C/EBPα and C/EBPβ binding proteins modulate hepatocyte apoptosis through iNOS signaling pathway.
Wang K; Brems JJ; Gamelli RL; Holterman AX
Biochim Biophys Acta; 2011 Aug; 1813(8):1395-403. PubMed ID: 21539866
[TBL] [Abstract][Full Text] [Related]
22. Effect of phosphorylation and S-S bond-induced dimerization on DNA binding and transcriptional activation by C/EBPbeta.
Kim JW; Tang QQ; Li X; Lane MD
Proc Natl Acad Sci U S A; 2007 Feb; 104(6):1800-4. PubMed ID: 17264204
[TBL] [Abstract][Full Text] [Related]
23. Cell cycle-dependent phosphorylation of C/EBPbeta mediates oncogenic cooperativity between C/EBPbeta and H-RasV12.
Shuman JD; Sebastian T; Kaldis P; Copeland TD; Zhu S; Smart RC; Johnson PF
Mol Cell Biol; 2004 Sep; 24(17):7380-91. PubMed ID: 15314150
[TBL] [Abstract][Full Text] [Related]
24. Complement component 3 (C3) expression in the hippocampus after excitotoxic injury: role of C/EBPβ.
Hernandez-Encinas E; Aguilar-Morante D; Morales-Garcia JA; Gine E; Sanz-SanCristobal M; Santos A; Perez-Castillo A
J Neuroinflammation; 2016 Oct; 13(1):276. PubMed ID: 27769255
[TBL] [Abstract][Full Text] [Related]
25. Regulation of Pancreatic β Cell Mass by Cross-Interaction between CCAAT Enhancer Binding Protein β Induced by Endoplasmic Reticulum Stress and AMP-Activated Protein Kinase Activity.
Matsuda T; Takahashi H; Mieda Y; Shimizu S; Kawamoto T; Matsuura Y; Takai T; Suzuki E; Kanno A; Koyanagi-Kimura M; Asahara S; Bartolome A; Yokoi N; Inoue H; Ogawa W; Seino S; Kido Y
PLoS One; 2015; 10(6):e0130757. PubMed ID: 26091000
[TBL] [Abstract][Full Text] [Related]
26. CCAAT/enhancer binding protein beta protects muscle satellite cells from apoptosis after injury and in cancer cachexia.
Marchildon F; Fu D; Lala-Tabbert N; Wiper-Bergeron N
Cell Death Dis; 2016 Feb; 7(2):e2109. PubMed ID: 26913600
[TBL] [Abstract][Full Text] [Related]
27. Role of cdk2 in the sequential phosphorylation/activation of C/EBPbeta during adipocyte differentiation.
Li X; Kim JW; Grønborg M; Urlaub H; Lane MD; Tang QQ
Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11597-602. PubMed ID: 17601773
[TBL] [Abstract][Full Text] [Related]
28. CCAAT/enhancer-binding protein beta is required for activation of genes for ornithine cycle enzymes by glucocorticoids and glucagon in primary-cultured hepatocytes.
Kimura T; Chowdhury S; Tanaka T; Shimizu A; Iwase K; Oyadomari S; Gotoh T; Matsuzaki H; Mori M; Akira S; Takiguchi M
FEBS Lett; 2001 Apr; 494(1-2):105-11. PubMed ID: 11297744
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of collagen gene expression by interferon-gamma: novel role of the CCAAT/enhancer binding protein beta (C/EBPbeta).
Ghosh AK; Bhattacharyya S; Mori Y; Varga J
J Cell Physiol; 2006 Apr; 207(1):251-60. PubMed ID: 16331681
[TBL] [Abstract][Full Text] [Related]
30. Functional cooperation between CCAAT/enhancer-binding proteins and the vitamin D receptor in regulation of 25-hydroxyvitamin D3 24-hydroxylase.
Dhawan P; Peng X; Sutton AL; MacDonald PN; Croniger CM; Trautwein C; Centrella M; McCarthy TL; Christakos S
Mol Cell Biol; 2005 Jan; 25(1):472-87. PubMed ID: 15601867
[TBL] [Abstract][Full Text] [Related]
31. v-Myc inhibits C/EBPbeta activity by preventing C/EBPbeta-induced phosphorylation of the co-activator p300.
Steinmann S; Schulte K; Beck K; Chachra S; Bujnicki T; Klempnauer KH
Oncogene; 2009 Jul; 28(26):2446-55. PubMed ID: 19448669
[TBL] [Abstract][Full Text] [Related]
32. CCAAT/enhancer binding protein β directly regulates the expression of the complement component 3 gene in neural cells: implications for the pro-inflammatory effects of this transcription factor.
Hernandez-Encinas E; Aguilar-Morante D; Cortes-Canteli M; Morales-Garcia JA; Gine E; Santos A; Perez-Castillo A
J Neuroinflammation; 2015 Jan; 12():14. PubMed ID: 25617152
[TBL] [Abstract][Full Text] [Related]
33. Phosphorylation of C/EBPbeta at a consensus extracellular signal-regulated kinase/glycogen synthase kinase 3 site is required for the induction of adiponectin gene expression during the differentiation of mouse fibroblasts into adipocytes.
Park BH; Qiang L; Farmer SR
Mol Cell Biol; 2004 Oct; 24(19):8671-80. PubMed ID: 15367685
[TBL] [Abstract][Full Text] [Related]
34. A role for CCAAT/enhancer binding protein beta-liver-enriched inhibitory protein in mammary epithelial cell proliferation.
Zahnow CA; Cardiff RD; Laucirica R; Medina D; Rosen JM
Cancer Res; 2001 Jan; 61(1):261-9. PubMed ID: 11196172
[TBL] [Abstract][Full Text] [Related]
35. C/EBPbeta contributes to hepatocyte growth factor-induced replication of rodent hepatocytes.
Wang B; Gao C; Ponder KP
J Hepatol; 2005 Aug; 43(2):294-302. PubMed ID: 15922473
[TBL] [Abstract][Full Text] [Related]
36. Involvement of C/EBPβ-related signaling pathway in methamphetamine-induced neuronal autophagy and apoptosis.
Huang E; Huang H; Guan T; Liu C; Qu D; Xu Y; Yang J; Yan L; Xiong Y; Liang T; Wang Q; Chen L
Toxicol Lett; 2019 Sep; 312():11-21. PubMed ID: 31059759
[TBL] [Abstract][Full Text] [Related]
37. Expression and DNA-binding activity of C/EBPalpha and C/EBPbeta in human liver and differentiated primary hepatocytes.
Ferrini JB; Rodrigues E; Dulic V; Pichard-Garcia L; Fabr JM; Blanc P; Maurel P
J Hepatol; 2001 Aug; 35(2):170-7. PubMed ID: 11580138
[TBL] [Abstract][Full Text] [Related]
38. Essential role of phosphatidylinositol 3-kinase-dependent CCAAT/enhancer binding protein beta activation in the induction of glutathione S-transferase by oltipraz.
Kang KW; Cho IJ; Lee CH; Kim SG
J Natl Cancer Inst; 2003 Jan; 95(1):53-66. PubMed ID: 12509401
[TBL] [Abstract][Full Text] [Related]
39. Arachidonic acid regulation of the cytosolic phospholipase A 2α/cyclooxygenase-2 pathway in mouse endometrial stromal cells.
Zhao ZA; Zhang ZR; Xu X; Deng WB; Li M; Leng JY; Liang XH; Yang ZM
Fertil Steril; 2012 May; 97(5):1199-205.e1-9. PubMed ID: 22369775
[TBL] [Abstract][Full Text] [Related]
40. CCAAT/enhancer-binding protein beta (nuclear factor for interleukin 6) transactivates the human MDR1 gene by interaction with an inverted CCAAT box in human cancer cells.
Chen KG; Sale S; Tan T; Ermoian RP; Sikic BI
Mol Pharmacol; 2004 Apr; 65(4):906-16. PubMed ID: 15044620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
